Skip to main content

Application of PET and PET-CT in Cancer of the Gastrointestinal System

  • Chapter
  • First Online:
Positron Emission Tomography

Abstract

Esophageal and gastric cancers are highly aggressive malignancies with poor prognosis. Surgical resection is the primary curative treatment for early esophageal and gastric cancers. Multimodality treatment involving preoperative chemotherapy with or without radiation followed by surgical resection in suitable patients is increasingly becoming popular in patients who have locally advanced cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

For Further Reading

  1. Bang S, Chung HW, Park SW, et al. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterol. 2006;40:923–9.

    Article  PubMed  Google Scholar 

  2. Chen J, Cheong JH, Yun MJ, Kim J, Lim JS, Hyung WJ, et al. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer. 2005;103:2383–90.

    Article  PubMed  Google Scholar 

  3. Dierckx R, Maes A, Peeters M, Van De Wiele C. FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases. Q J Nucl Med Mol Imaging. 2009;53:336–42.

    CAS  PubMed  Google Scholar 

  4. Gayed I, Vu T, Iyer R, et al. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004;45:17–21.

    CAS  PubMed  Google Scholar 

  5. Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol. 2008;14:3773–80.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic or recurrent gastric cancer. J Nucl Med. 2003;44:690–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. R. Mittal MD, FICNM, FAMS .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer India

About this chapter

Cite this chapter

Mittal, B.R., Parghane, R., Roop, J.M. (2015). Application of PET and PET-CT in Cancer of the Gastrointestinal System. In: Das, B. (eds) Positron Emission Tomography. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2098-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-81-322-2098-5_13

  • Published:

  • Publisher Name: Springer, New Delhi

  • Print ISBN: 978-81-322-2097-8

  • Online ISBN: 978-81-322-2098-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics